Log in to save to my catalogue

Peptide-based anti-PCSK9 vaccines - an approach for long-term LDLc management

Peptide-based anti-PCSK9 vaccines - an approach for long-term LDLc management

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1630366375

Peptide-based anti-PCSK9 vaccines - an approach for long-term LDLc management

About this item

Full title

Peptide-based anti-PCSK9 vaccines - an approach for long-term LDLc management

Publisher

United States: Public Library of Science

Journal title

PloS one, 2014-12, Vol.9 (12), p.e114469-e114469

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Low Density Lipoprotein (LDL) hypercholesterolemia, and its associated cardiovascular diseases, are some of the leading causes of death worldwide. The ability of proprotein convertase subtilisin/kexin 9 (PCSK9) to modulate circulating LDL cholesterol (LDLc) concentrations made it a very attractive target for LDLc management. To date, the most advan...

Alternative Titles

Full title

Peptide-based anti-PCSK9 vaccines - an approach for long-term LDLc management

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1630366375

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1630366375

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0114469

How to access this item